Minev Boris Radoslavov

Calidi Biotherapeutics, Inc. · Interim Chief Medical Officer

Minev Boris Radoslavov is listed in filings as Interim Chief Medical Officer at Calidi Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 20, 2024, including 1 public disclosure. Recent filings connect the profile to Calidi Biotherapeutics, Inc. (CLDI). The current snapshot covers public activity from Jun 20, 2024. Reported amounts are shown as $6.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.